药物基因组学

目前,临床上最常见的一个现象就是不同的病人对同一种药物有不同的反应,这一直是困扰临床治疗的一个重大问题。近几年来,人们发现这些差异大多源于基因差异,基于此,有人提出“药物基因组学”的概念,它主要研究病人对药物的反应是如何受其基因影响的,以解决为什么不同的病人对同一种药物有不同反应的临床难题。基因多态性是药物基因组学的分子基础。影响药物作用的遗传差异的发现将导致新的诊断程序和治疗产品的开发,从而可以有选择地给病人用药,做到既有效又安全。1.药物基因组学的诞生早在50年代,人们就已经发现不同的遗传背景会导致药物反…     

药物基因组学相关P450和ABCB1多态性及SNP检测技术

药物基因组学（phamacogenomics）是临床检测遗传差异引起药物应答个体性差异的学科,它涉及药物代谢和有害的药物反应的预测等方面的内容。个性化药物和个性化治疗发展的关键条件是能够快速简便的检测出病人的遗传多态性。文章综述了药物基因相关问题,细胞色素酶1）450和ABCB1转运蛋白的遗传多态性以及检测遗传多态性的相关技术。     

药物基因组学——个性化药物的开发

药物基因组学是研究药物反应的遗传机制及药物反应的个体差异性。本文详细讨论了药物基因组学的发展历史,种族,个体的遗传差异性对药物反应的影响;介绍了当前人事药物基因组学开发研究的公司情况及医药管理机构关于药物基因组这的指导性文件;本文也论述了遗传多态性及疾病诊断和疾病相关基因鉴定的最新研究进展。     

人类基因组单核苷酸多态性的研究进展

随着分子遗传学的进展 ,疾病遗传学研究从简单的单基因疾病转向复杂的多基因疾病 (如骨质疏松症、糖尿病、心血管疾病、精神性紊乱、各种肿瘤等 )与药物基因组学的研究。与前者相比 ,多基因性状或遗传病的形成 ,受许多对微效加性基因作用。这些不同基因构成的遗传背景中 ,可能有易感性主基因 (ｍａｊｏｒｇｅｎｅ)起着重要作用。它们同时还受环境因素的制约 ,彼此间相互作用错综复杂 ,所以任一基因的多态性对疾病发生仅起微弱的作用。鉴于此 ,需要在人类基因组中找到一种数目多、分布广泛且相对稳定的遗传标记。单核苷酸多态性 (ｓｉｎｇｌ…     

基于生物信息学的SNP候选位点搜寻方法

单核苷酸多态性（Single Nucleotide Polymorphism,SNP)是人类基因组中最常见的遗传多态,在遗传学研究的很多方面具有重要的作用。它的搜寻正受到广泛关注。近年来,国际上出现了一种基于生物信息学的发掘SNP新方法,本对方法的两种策略及其各自所存在的问题作一介绍。     

药物相关转运蛋白基因多态性的研究进展

药物相关转运蛋白不但与肿瘤多药耐药现象密切相关,而且在人体内广泛参与药物的吸收、分布、代谢和排泄等过程。其编码基因的单核苷酸多态性(singlenucleotidepolymorphism,SNP)位点变异可能与药物转运蛋白的表达、转运功能密切相关,决定了临床常见的个体/群体药物反应差异性。本文主要介绍了近年来有关药物相关转运蛋白SNP位点基因多态性,以及与临床常见表型相关性的研究。     

药物基因组学——个性化药物的开发

药物基因组学是研究药物反应的遗传机制及药物反应的个体差异性。本文详细讨论了药物基因组学的发展历史,种族,个体的遗传差异性对药物反应的影响;介绍了当前从事药物基因组学开发研究的公司情况及医药管理机构关于药物基因组学的指导性文件;本文也论述了遗传多态性及疾病诊断和疾病相关基因鉴定的最新研究进展 。     

高通量SNP基因分型技术研究进展

在后基因组时代,单核苷酸多态性研究已迅速成为了生物医学许多领域的焦点。发展可靠、敏感、经济、稳定、高通量的SNP基因分型技术已迫在眉睫。本文主要着重于高通量SNP基因分型技术的原理、利弊以及这些技术在这个领域过去几年中的进展。     

单核苷酸多态性研究进展及其在医学中的应用

单核苷酸多态性（single nucleotide polymorphism,SNP）是人类基因组中单个碱基的变异,其最低基因频率不低于1％,是被受关注的第三代多态性遗传标记,为医学、药学等研究提供了新的方向,其在复杂疾病、遗传病研究及法医中个体识别、亲权鉴定和药学研究方面都有重要作用,本文就其研究最新进展、应用及检测手段作一综述。     

海洋生物单核苷酸多态性基因分型技术的研究进展

单核苷酸多态性(single nucleotide polymorphism,SNP)是一类广泛分布于基因组中由单个碱基差异引起的DNA序列变异,SNP标记是第三代分子标记的代表。随着大规模测序技术的快速发展,大量的候选SNP位点被发现,候选SNP位点的发掘需要合适的分型技术。从等位基因分型机制、反应方式和检测等位基因方法等方面介绍当前海洋生物SNP分型技术的研究进展,以期为不同试验目的的研究选择合适的SNP分型技术提供参考。     

Approaches to antiviral drug development

At present, only a few drugs have been approved by the FDA for therapy of viral infections in humans. There is a great need for antiviral drugs with increased potency and decreased toxicity, as well as drugs to treat viral diseases for which no drug or vaccine is currently available. Two approaches for development of antiviral drugs are described--an empirical strategy and a rational strategy--with several examples of each. Although many compounds have potent antiviral activity in cell culture, only a small fraction of these will go on to become antiviral drugs for use in humans. At this time, only seven synthetic compounds and alpha interferon have been approved by the FDA for therapy of viral infections in humans. None of these approved drugs are without toxicities, however, and hence there is a great need for antiviral drugs with increased potency and decreased toxicity, as well as for drugs to treat viral diseases for which no drug or vaccine is currently available. Two approaches for the development of antiviral drugs--the empirical and the rational strategies--and their applications and future directions are discussed.     

Mutations in somePolycomb group genes ofDrosophila interfere with regulation of segmentation genes

Mutations in severalPolycomb (Pc) group genes cause maternal-effect or zygotic segmentation defects, suggesting thatPc group genes may regulate the segmentation genes ofDrosophila. We show that individuals doubly heterozygous for mutations inpolyhomeotic and six otherPc group genes show gap, pair rule, and segment polarity segmentation defects. We examined double heterozygous combinations ofPc group and segmentation mutations for enhancement of adult and embryonic segmentation defects.Posterior sex combs andpolyhomeotic interact withKrüppel ² and enhance embryonic phenotypes ofhunchback andknirps, andpolyhomeotic enhanceseven-skipped. Surprisingly, flies carrying duplications ofextra sex combs (esc), that were heterozygous for mutations ofeven-skipped (eve), were extremely subvital. Embryos and surviving adults of this genotype showed strong segmentation defects in even-numbered segments. Antibody studies confirm that expression ofeve is suppressed by duplications ofesc. However,esc duplications have no effect on other gap or pair rule genes tested. To our knowledge, this is only the second triplo-abnormal phenotype associated withPc group genes. Duplications of nine otherPc group genes have no detectable effect oneve. Expression ofengrailed (en) was abnormal in the central nervous systems of mostPc group mutants. These results support a role forPc genes in regulation of some segmentation genes, and suggest thatesc may act differently from otherPc group genes.     

Approaches to cloning genes encoding for nutrient transporters in plants

Pairs of fungi were incubated on wheat straw in microcosms for 10 weeks. Release of Na⁺, K⁺ and NH₄ ⁺-N was similar from all combinations, but Ca²⁺, Mg²⁺ and PO₄ ^3--P release depended on the species. In Agrocybe gibberosa/Chaetomium globosum and Sphaerobolus stellatus/Chaetomium globosum combinations, there was evidence of interactions which suppressed the predicted rate of phosphate release, and in all the mixed species combinations there were interactions which increased the rate of fungal respiration above that of the more combative fungus in pure culture. ei]{gnR}{fnMerckx}     

Tumour suppressor genes in chemotherapeutic drug response

Since cancer is one of the leading causes of death worldwide, there is an urgent need to find better treatments. Currently, the use of chemotherapeutics remains the predominant option for cancer therapy. However, one of the major obstacles for successful cancer therapy using these chemotherapeutics is that patients often do not respond or eventually develop resistance after initial treatment. Therefore identification of genes involved in chemotherapeutic response is critical for predicting tumour response and treating drug-resistant cancer patients. A group of genes commonly lost or inactivated are tumour suppressor genes, which can promote the initiation and progression of cancer through regulation of various biological processes such as cell proliferation, cell death and cell migration/invasion. Recently, mounting evidence suggests that these tumour suppressor genes also play a very important role in the response of cancers to a variety of chemotherapeutic drugs. In the present review, we will provide a comprehensive overview on how major tumour suppressor genes [Rb (retinoblastoma), p53 family, cyclin-dependent kinase inhibitors, BRCA1 (breast-cancer susceptibility gene 1), PTEN (phosphatase and tensin homologue deleted on chromosome 10), Hippo pathway, etc.] are involved in chemotherapeutic drug response and discuss their applications in predicting the clinical outcome of chemotherapy for cancer patients. We also propose that tumour suppressor genes are critical chemotherapeutic targets for the successful treatment of drug-resistant cancer patients in future applications.     

Evolution of primate ABO blood group genes and their homologous genes

There are three common alleles (A, B, and O) at the human ABO blood group locus. We compared nucleotide sequences of these alleles, and relatively large numbers of nucleotide differences were found among them. These differences correspond to the divergence time of at least a few million years, which is unusually large for a human allelic divergence under neutral evolution. We constructed phylogenetic networks of human and nonhuman primate ABO alleles, and at least three independent appearances of B alleles from the ancestral A form were observed. These results suggest that some kind of balancing selection may have been operating at the ABO locus. We also constructed phylogenetic trees of ABO and their evolutionarily related alpha-1,3- galactosyltransferase genes, and the divergence time between these two families was estimated to be roughly 400 MYA.      

Animal histo-blood group ABO genes.

Sequences homologous to the human histo-blood group ABO genes are present in the genomic DNA of various mammals. We have PCR-amplified, subcloned, and sequenced a portion of these genes from several species of primates and found high conservation of the nucleotide as well as the deduced amino acid sequences during evolution.     

细菌的群体性行为与耐药

随着抗生素的广泛使用,细菌耐药已经成为一个严重的问题。细菌耐药是一个复杂的过程,涉及宿主、细菌与环境等几个既相互独立又相互作用的因素。很久以来,人们认为细菌以个体为单位进行各种活动,直到发现细菌相互之间也存在联系,才意识到细菌群体对其个体生存的重要性。目前将细菌作为一个群体来研究其耐药行为与机制的研究越来越多,特别是细菌生物膜与细菌程序性死亡两方面受到极大重视。本文综述了细菌生物膜、细菌程序性死亡与耐药相关机制的研究进展。     

Phototaxis genes on linkage group V in Dictyostelium discoideum

Abstract During the course of mapping and complementation analysis of phototaxis ( pho ) mutations in Dictyostelium discoideum we have assigned to linkage group V three mutant pho alleles belonging to complementation groups phoG and phoK . These are the first genetic markers with an easily recognizable phenotype to be found on this linkage group.